BD-300

N/A

Report date: 2024/09/25 10:55:23

Base Information

Drug NameBD-300

Drug Alias NameBD-300

ClassificationOther

Mechanisms of ActionRegulatory T-lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiolojic Design Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

ATC CodeN/A